Wikidata

(Q64123071)

English

Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®

clinical trial

In more languages

Statements

title
Safety and Efficacy With Twice Daily Brinzolamide 1%/Brimonidine 0.2% (SIMBRINZA®) as an Adjunctive Therapy to Travoprost 0.004%/Timolol 0.5% (DUOTRAV®) (English)
0 references
start time
24 June 2016
0 references
end time
13 July 2018
0 references
number of participants
173
0 references
research intervention
travoprost
0 references
brinzolamide
0 references
cloprostenol
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64123071&oldid=1857553575"